Organometallic compound and organic light-emitting device including the same

US10043986B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10043986-B2
Application numberUS-201514680488-A
CountryUS
Kind codeB2
Filing dateApr 7, 2015
Priority dateMay 7, 2014
Publication dateAug 7, 2018
Grant dateAug 7, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An organometallic compound represented by Formula 1: wherein in Formula 1, M, L 1 , n1, n2, and R 41 to R 47 are described in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. An organometallic compound represented by Formula 1, wherein L 1 in Formula 1 comprises at least one selected from a first ligand represented by Formulae 2A-1 to 2A-27 and 2A-29 to 2A-45, a second ligand represented by Formula 2B, and a third ligand represented by one selected from Formulae 2C, 2D, and 2E: wherein, in Formulae 2 A- 1 to 2 A- 45 , Z 1 , Z 2 , Z 11 to Z 13 , and Q 46 to Q 49 are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, —SF 5 , a C 1 -C 20 alkyl group, and a C 1 -C 20 alkoxy group; a C 1 -C 20 alkyl group and a C 1 -C 20 alkoxy group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group; a phenyl group, a naphthyl group, a fluorenyl group, a phenantherenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, an isothizolyl group, an oxazolyl group, an isooxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a guinolinyl group, an isoguinolinyl group, a benzoguinolinyl group, a guinoxalinyl group, a guinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzooxazolyl group, an isobenzooxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group; and a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isooxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a guinolinyl group, an isoguinolinyl group, a benzoguinolinyl group, a guinoxalinyl group, a guinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzooxazolyl group, an isobenzooxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group, each substituted with at least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, carboxylic acid group or a salt thereof, squonic acid group or a salt thereof, phosphoric acid group or a salt thereof, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isooxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a guinolinyl group, an isoguinolinyl group, a benzoguinolinyl group, a guinoxalinyl group, a guinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzooxazolyl group, an isobenzooxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group; aa1 is an integer selected from 1 to 4; ab1 and ab2 are each independently integers selected from 1 to 3; ac1 and a02 are each independently 1 or 2; and * and *’are binding sites to M in Formula 1, in Formulae 1, 2B to 2E, and 3 above, M is selected from Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, and Tm; CY 3 and CY 4 are each independently a C 2 -C 60 heterocyclic group comprising at least one N; X 1 is N or CR 1 , X 2 is N or CR 2 , X 3 is N or CR 3 , X 4 is N or CR 4 , X 11 is N or CR 11 , X 12 is N or CR 12 , X 13 is N or CR 13 , X 14 is N or CR 14 , X 15 is N or CR 15 , and X 16 is N or CR 16 ; Z 32 is selected from *—O—*′, *—S—*′, *—N(Q 51 )—*′, *—C(Q 52 )(Q 53 )—*′, *—C(Q 54 )═C(Q 55 )—*′, and b2 is an integer selected from 1 to 10, and when b2 is 2 or greater, groups Z 32 are the same or different; R 41 to R 47 , Z 3 to Z 6 , R 1 to R 4 , R 11 to R 16 , and Q 51 to Q 59 are each independently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, —SF 5 , a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10043986B2 cover?
An organometallic compound represented by Formula 1: wherein in Formula 1, M, L 1 , n1, n2, and R 41 to R 47 are described in the specification.
Who is the assignee on this patent?
Samsung Electronics Co Ltd, Samsung Sdi Co Ltd
What technology area does this patent fall under?
Primary CPC classification H01L51/0085. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).